Sh Fosun Pharma | 600196 - Equity Capital And Reserves


Sh Fosun Pharma reported CNY49.15B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Cspc Pharmaceutical CNY 33.18B 71.46M Dec/2025
Jiangsu Hengrui CNY 63.63B 2.35B Mar/2026
Kangmei Pharma CNY 7.31B 84.82M Mar/2026
Sh Pharmaceutical CNY 76.4B 615.53M Dec/2025
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
Wuxi Apptec CNY 84.77B 4.11B Mar/2026
Zz Pientze Pharmaceu CNY 15.21B 740.32M Mar/2026